Download announcement as PDF
Thor Medical ASA: Invitation to Presentation of Half-Year 2026 Results
2026-08-19 07:00:29
19.8.2026 07:00:08 CEST | Thor Medical ASA | Non-regulatory press releases
Thor Medical ASA will publish its financial results for the first half of 2026
on Friday, August 28, 2026, at 07:00 CEST.
The company will host a presentation of the results at 08:00 CEST on the same
day at Sjølyst Møtesenter, Drammensveien 165, Oslo. Investors, analysts and
media are invited to attend.
Date: Friday, August 28, 2026
Time: 08:00 CEST
Venue: Sjølyst Møtesenter, Drammensveien 165, Oslo
Webcast: https://qcnl.tv/p/fw_5KqTHcjfYMddAq3--1A
The financial report for the first half of 2026 and the presentation material
will be published at 07:00 CEST and will be available at www.thormedical.com -
http://www.thormedical.com/.
CONTACTS
* Mathias Nilsen Reierth, Head of Communications and Corporate Affairs, +47 988
05 724, mathias.reierth@thormedical.com
ABOUT THOR MEDICAL ASA
ABOUT THOR MEDICAL ASA
Thor Medical is a leading supplier of high-purity isotopes to the
radiopharmaceutical industry. The Company's proprietary production platform
combines advanced separation technology with industrial-scale manufacturing
capacity to deliver a reliable, scalable and cost-efficient supply of
alpha-emitting radioisotopes. Thor Medical supports radiopharmaceutical
companies from early-stage development to commercialization enabling scale-up of
next-generation targeted cancer therapies.
Thor Medical's product portfolio includes lead-212 (Pb-212) and its precursor
isotopes thorium-228 (Th-228) and radium-224 (Ra-224). Based on naturally
occurring thorium, Thor Medical's production process requires neither
irradiation nor nuclear reactors, providing significant cost advantages while
minimizing radioactive waste.
Guided by its vision to become a world-leading enabler for targeted cancer
therapies, Thor Medical is committed to improving millions of lives by powering
the next generation of precision cancer treatment with high-purity isotopes.
Thor Medical is headquartered in Oslo, Norway, and listed on the Oslo Stock
Exchange under the ticker symbol TRMED. For more information, visit
www.thormedical.com - http://www.thormedical.com.
ATTACHMENTS
Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/19028648/15346/Download%20announc
ement%20as%20PDF.pdf
/ir-files/17848634/19028648/15346/Download%20announc\
ement%20as%20PDF.pdf\